Korean Practice Patterns for Screening PCA(Prostate Cancer) (RESPECT)

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Neoplasms, Prostate; Benign Prostatic Hyperplasia; Prostate Cancer

Treatments: Other: continuous screening

Study type: Observational

Funder types: Industry

Identifiers

NCT01371513

113951

Details and patient eligibility

About

This is to investigate Korean urologist's practice patterns for screening prostate cancer according to PSA level.

Full description

This is to investigate Korean urologist's practice patterns for screening prostate cancer according to PSA level.

Enrollment: 1 patient

Sex: Male

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male with PSA more than 2.5ng/ml from 1 Jan 2008 to 31 Dec 2008

Exclusion criteria

• Age less than 40 at PSA screening
• History of drug use which can affect level of PSA within 6months before PSA screening
• Subject who participate any other clinical trial

Trial design

1 participants in 1 patient group

PSA level

Description:

more than 2.5ng/ml

Treatment:

Other: continuous screening